Solcovagyn, 0.5ml vials, 2pcs

Composition

1 ml of the solution contains

nitric acid 70% 537 mg,

acetic acid 99% 20.4 mg,

oxalic acid dihydrate 58.6 mg,

zinc nitrate hexahydrate 6 mg,

distilled water up to 1 ml

Pharmacological action

Pharmaceutical group:

A drug for the treatment of benign lesions of the cervix.

Pharmaceutical action:

 Solcovagyn is a drug for the topical treatment of benign lesions of the superficial tissues of the cervix. When using the drug, there is a different effect on different types of cervical epithelium.

 When the drug is applied to the ectopic cylindrical epithelium (cervical ectopia and transformation zone) and subepithelial stroma (cervical erosion), they are immediately devitalized and fixed in vivo. On the other hand, the multilayered cellular structures of the squamous epithelium of the vaginal part of the cervix and the vaginal mucosa, which are more resistant to the effects of Solcovagyn, remain practically intact.

Devitalization and fixation of the altered tissue occurs within a few minutes and is accompanied by the appearance of yellowish-white or gray staining of the tissue. This phenomenon cannot be classified as a cauterizing effect of acids in the usual view, since the devitalized (necrotic) epithelium remains in its place in the initial phase and forms a protective layer that peels off after a few days due to the spontaneous growth of new squamous epithelial cells under it.

Pharmacokinetics:  

Solcovagyn is effective only at the site of application. No systemic absorption is observed.

Indications

Benign lesions of the surface tissues of the cervix: cervical ectopia, transformation zone, nabotov cysts (after opening), polyps of the cervical canal (in the absence of endometrial pathology), postoperative granulomas.

Contraindications

Malignant changes in the cervix or suspected malignancy, cellular dysplasia, pregnancy, hypersensitivity to the components of the drug.

Side effects

To date, no side effects have been observed with the use of Solcovagyn.

The treatment is painless and does not lead to scarring or deformity of the cervical canal.

Interaction

To date, no cases of interaction of Solcovagyn with other drugs have been reported.

How to take, course of use and dosage

Solcovagyn is applied topically.

The procedure should only be performed by a gynecologist (using a colposcope).

During the procedure, only the affected area should be treated, avoiding contact with the solution on the skin of the external genitalia and the epithelium of the vagina.

Overdose

Symptoms: excessive use of the drug may cause burns, which can lead to pathological changes in the cervical epithelium.

Treatment: symptomatic.

Special instructions

Treatment with Solcovagyn is carried out on an outpatient basis and does not provide for any restrictions in taking water procedures and conducting sexual activity.

Avoid contact with clothing, skin, and especially eyes.

If Solcovagyn solution gets on the skin of the external genitalia or the epithelium of the vagina, immediately flush the area of contact with the drug with water.

If Solcovagyn solution comes into contact with the skin or eyes, immediately flush the area of contact with the drug with copious amounts of water and, if possible, with a neutralizing solution, such as 1% sodium bicarbonate solution.

After the procedure, place the used cotton swab in the bottle for 1 cm, break off the rod, close the bottle with the stopper provided in the package to avoid getting the remaining solution on surrounding objects, then throw it into a garbage container.

Form of production

Solution for topical application

Storage conditions

Store in a dry place, protected from light, at a temperature not exceeding 20 °C.

Shelf life

3 years

Active ingredient

Acetic Acid, Nitric Acid, Oxalic acid Dihydrate, Zinc Nitrate Hexahydrate

Conditions of release from pharmacies

By prescription

Dosage form

solution for topical application

Description

Adults on doctor’s prescription